Oppenheimer Asset Management’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Oppenheimer Asset Management’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-17,219	Closed	-$99K	–	1231
2022 Q1	$99K	Buy	17,219 +5,106	+42%	+$45.8K	﹤0.01%	1187
2021 Q4	$182K	Sell	12,113 -4,687	-28%	-$85.3K	﹤0.01%	1182
2021 Q3	$440K	Buy	16,800 +694	+4%	+$25.6K	0.01%	966
2021 Q2	$805K	Buy	16,106 +2,677	+20%	+$120K	0.01%	813
2021 Q1	$618K	Sell	13,429 -3,596	-21%	-$172K	0.01%	863
2020 Q4	$729K	Buy	17,025 +880	+5%	+$33.4K	0.01%	783
2020 Q3	$658K	Buy	16,145 +3,120	+24%	+$155K	0.01%	739
2020 Q2	$713K	Buy	13,025 +7,967	+158%	+$456K	0.01%	693
2020 Q1	$264K	Buy	5,058 +2,743	+118%	+$148K	0.01%	902
2019 Q4	$113K	Buy	2,315 +1,419	+158%	+$66.4K	﹤0.01%	1171
2019 Q3	$49K	Buy	+896	New	+$51.3K	﹤0.01%	1346
2019 Q2	–	Sell	-1,382	Closed	-$78K	–	1669
2019 Q1	$78K	Sell	1,382 -730	-35%	-$43.5K	﹤0.01%	1279
2018 Q4	$135K	Buy	+2,112	New	+$150K	﹤0.01%	1113

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Oppenheimer Asset Management's TRHC Position: Q2 2022 in Review

Oppenheimer Asset Management sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q2 2022, closing a stake of 17,219 shares — an estimated $99K sold.

Oppenheimer Asset Management first reported a position in TRHC in Q4 2018 and held it in 13 quarters. The position peaked at $805K in Q2 2021. 96 funds tracked by Wall St. Rank hold TRHC as of Q2 2022.

Oppenheimer Asset Management reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Oppenheimer Asset Management sold 17,219 Tabula Rasa HealthCare, Inc. Common Stock shares in Q2 2022, an estimated $99K.
Oppenheimer Asset Management first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q4 2018 and held it in 13 quarters.
Oppenheimer Asset Management's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $805K in Q2 2021.
96 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q2 2022.

Based on Oppenheimer Asset Management's 13F filing for Q2 2022, filed 8 Aug 2022.